SCHEMBL7659484

SCHEMBL7659484

CN(C)C1CCc2[nH]c3ccc(NC(=O)Nc4ccccc4)cc3c2C1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 1/20 0.69
KMT2A Q03164 4/20 0.48
BRD4 O60885 1/20 0.48
MEN1 O00255 3/20 0.46
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
CASP1 P29466 1/20 0.44
HTR1B P28222 2/20 0.43
HTR1A P08908 1/20 0.43
HTR1D P28221 1/20 0.43
LMNA P02545 2/20 0.41
MAPK1 P28482 1/20 0.41
HTR6 P50406 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656398 0.90 HTR1F (0.81) HTR1FKMT2ABRD4MEN1L3MBTL1
SCHEMBL7660717 0.90 HTR1F (0.63) HTR1FKMT2AMEN1L3MBTL1MAPT
SCHEMBL11334169 0.87 HTR1F (0.74) HTR1FKMT2AMEN1MAPTKDM4E
SCHEMBL7655520 0.87 HTR1F (0.68) HTR1FKMT2AMEN1L3MBTL1MAPT
SCHEMBL7662212 0.86 HTR1F (0.79) HTR1FKMT2ABRD4MEN1L3MBTL1
SCHEMBL7664670 0.86 HTR1F (0.65) HTR1FKMT2AMEN1L3MBTL1MAPT
SCHEMBL7663867 0.85 HTR1F (0.71) HTR1FKMT2AMEN1MAPTKDM4E
SCHEMBL7407071 0.85 HTR1F (0.71) HTR1FKMT2AMEN1L3MBTL1MAPT
SCHEMBL7666163 0.85 HTR1F (0.71) HTR1FKMT2AMEN1MAPTKDM4E
SCHEMBL7656996 0.85 HTR1F (0.68) HTR1FKMT2AMEN1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0749962-B1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5814653-A SUMATRIPTAN FOR RELIEF OF MIGRAINE PAIN AND OTHER DISORDERS ASSOCIATED WITH PEPTIDE EXTRAVASATION DIE TO STUMULATION OF THE TRIGEMINAL GANGLIA; 5-HT 1F AGONISTS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
WO-1998006402-A1 TREATMENT OF THE COMMON COLD OR ALLERGIC RHINITIS ELI LILLY AND COMPANY (US) 1998-02-19 WO disclosed
US-5708187-A MIGRANE HEADACHES ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
EP-0749962-A1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles ELI LILLY AND COMPANY (US) 1996-12-27 EP disclosed